X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1133) 1133
Publication (129) 129
Data Set (5) 5
Book Review (4) 4
Conference Proceeding (2) 2
Book Chapter (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (757) 757
index medicus (726) 726
poloxamer - chemistry (610) 610
pharmacology & pharmacy (531) 531
humans (474) 474
male (353) 353
rats (292) 292
mice (257) 257
poloxamer (239) 239
poloxamer - pharmacology (231) 231
drug delivery systems (228) 228
nanoparticles (217) 217
particle size (207) 207
female (191) 191
drug-delivery (185) 185
drug carriers - chemistry (160) 160
in-vitro (145) 145
solubility (145) 145
micelles (144) 144
cell line, tumor (141) 141
rats, sprague-dawley (141) 141
temperature (136) 136
materials science, biomaterials (131) 131
nanoparticles - chemistry (129) 129
drugs (126) 126
gels (121) 121
chemistry, multidisciplinary (120) 120
delivery (115) 115
permeability (115) 115
analysis (113) 113
cell survival - drug effects (112) 112
poloxamer - administration & dosage (107) 107
biological availability (103) 103
chemistry, pharmaceutical (102) 102
block-copolymers (99) 99
cancer (98) 98
polyethylene glycols - chemistry (98) 98
hydrogels (93) 93
rats, wistar (91) 91
engineering, biomedical (90) 90
rabbits (90) 90
article (88) 88
drug carriers (87) 87
pluronic (87) 87
release (87) 87
vehicles (87) 87
nanoscience & nanotechnology (85) 85
pharmacokinetics (85) 85
surface properties (83) 83
time factors (83) 83
biochemistry & molecular biology (81) 81
polymers (81) 81
chemistry, medicinal (79) 79
poloxamer 407 (79) 79
polymers - chemistry (79) 79
drug compounding (77) 77
in-vivo (77) 77
cells (76) 76
cells, cultured (75) 75
poloxamer - metabolism (75) 75
bioavailability (74) 74
drug delivery systems - methods (72) 72
drug stability (72) 72
pharmacy (71) 71
tissue distribution (71) 71
viscosity (71) 71
disease models, animal (70) 70
excipients - chemistry (70) 70
surface-active agents - pharmacology (70) 70
surface-active agents - chemistry (69) 69
cell line (65) 65
formulation (65) 65
administration, oral (64) 64
skin - metabolism (64) 64
dose-response relationship, drug (63) 63
absorption (61) 61
swine (61) 61
in vitro techniques (60) 60
poloxamer - pharmacokinetics (60) 60
poly (60) 60
biotechnology & applied microbiology (59) 59
drug liberation (57) 57
rheology (57) 57
doxorubicin (56) 56
microspheres (56) 56
research (55) 55
chitosan (54) 54
kinetics (53) 53
medicine (53) 53
chitosan - chemistry (52) 52
hydrogel (52) 52
poloxamer 188 (52) 52
systems (52) 52
chemistry, physical (51) 51
drug (51) 51
liposomes (51) 51
proteins (51) 51
apoptosis (50) 50
chemistry, pharmaceutical - methods (49) 49
hydrogen-ion concentration (49) 49
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antioxidants & Redox Signaling, ISSN 1523-0864, 05/2015, Volume 22, Issue 13, pp. 184 - 1096
Aims: This study hypothesized that activation of endothelial nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 (Nlrp3)... 
Forum Original Research Communications | INDUCED GLOMERULAR INJURY | STERILE INFLAMMATION | HIGH-FAT DIET | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | THIOREDOXIN-INTERACTING PROTEIN | SMOOTH-MUSCLE-CELLS | NLRP3 INFLAMMASOME | REDOX SIGNALING PLATFORMS | ACID SPHINGOMYELINASE | NALP3 INFLAMMASOME | Acetylcholine - adverse effects | Inflammasomes - metabolism | Reactive Oxygen Species - metabolism | Pyroptosis - drug effects | NLR Family, Pyrin Domain-Containing 3 Protein | Caspase 1 - metabolism | Male | Coronary Vessels - metabolism | Inflammation - metabolism | Glycyrrhizic Acid - pharmacology | Hypercholesterolemia - pathology | HMGB1 Protein - metabolism | Superoxides - metabolism | Cytoskeletal Proteins - metabolism | Viral Proteins - pharmacology | Disease Models, Animal | Coronary Vessels - drug effects | Coronary Vessels - pathology | Endothelial Cells - metabolism | Bradykinin - adverse effects | Mice, Inbred C57BL | Receptors, Cell Surface - metabolism | Nucleotides - metabolism | Serpins - pharmacology | Pyrin | Animals | Carrier Proteins - metabolism | Poloxamer | Cholesterol - pharmacology | Hypercholesterolemia - chemically induced | Vasodilation - drug effects | Nitric Oxide - metabolism | Hypercholesterolemia - metabolism | Endothelial Cells - drug effects | Complications and side effects | Blood circulation disorders | Usage | Hypercholesterolemia | Confocal microscopy | Inflammation | Research | Risk factors | Index Medicus
Journal Article
Colloids and Surfaces B: Biointerfaces, ISSN 0927-7765, 06/2015, Volume 130, pp. 182 - 191
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 2010, Volume 390, Issue 1, pp. 61 - 69
The potential for colloidal carriers to increase drug bioavailability has spurred a renewed interest in their uptake mechanisms and movement within cells.... 
Nanoparticles | Cell uptake | Cell membrane | Resveratrol | Cell cycle | Nanomedicine | Controlled release | APOPTOSIS | PROTECTION | NLC | DRUG-DELIVERY | EPR | DELIVERY-SYSTEMS | INDUCTION | CANCER | SLN | PHARMACOLOGY & PHARMACY | LEUKEMIA | Stilbenes - administration & dosage | Nanoparticles - chemistry | Humans | Biological Availability | Delayed-Action Preparations - chemistry | Stilbenes - metabolism | Anticarcinogenic Agents - metabolism | Stilbenes - pharmacology | Drug Carriers - chemistry | Anticarcinogenic Agents - pharmacokinetics | Lipids - chemistry | Lecithins - chemistry | Anticarcinogenic Agents - administration & dosage | Delayed-Action Preparations - pharmacology | Metabolism - drug effects | Anticarcinogenic Agents - pharmacology | Poloxamer - chemistry | Drug Carriers - metabolism | Cell Size - drug effects | Keratinocytes - cytology | Static Electricity | Drug Carriers - pharmacology | Necrosis - chemically induced | Cell Shape - drug effects | Particle Size | Delayed-Action Preparations - metabolism | Keratinocytes - drug effects | Keratinocytes - metabolism | Intracellular Space - metabolism | Hydrophobic and Hydrophilic Interactions | Stilbenes - pharmacokinetics | Cell Proliferation - drug effects | Cell Cycle - drug effects | Cell Nucleus - drug effects | Cell Line, Transformed | Microscopy, Fluorescence
Journal Article
Journal Article
Journal Article
Toxicological Sciences, ISSN 1096-6080, 11/2007, Volume 100, Issue 1, pp. 303 - 315
The possible combination of specific physicochemical properties operating at unique sites of action within cells and tissues has led to considerable... 
Carbon nanotube | Albumin | Scavenger receptor | Inflammation | scavenger receptor | carbon nanotube | SIGNALING PATHWAYS | DRUG-DELIVERY | MACROPHAGES | MASS-SPECTROMETRY | CARBON NANOTUBES | NANOPARTICLES | IN-VITRO | inflammation | albumin | A SCAVENGER RECEPTORS | ENDOTHELIAL-CELLS | ULTRAFINE PARTICLES | TOXICOLOGY | Humans | Blood Proteins - metabolism | Receptors, Scavenger - antagonists & inhibitors | Anti-Inflammatory Agents - metabolism | Nanoparticles | Silicon Dioxide - metabolism | Nanotubes, Carbon - toxicity | Surface Properties | Receptors, Scavenger - metabolism | Poloxamer - chemistry | Cell Line | Reproducibility of Results | Anti-Inflammatory Agents - toxicity | Silicon Dioxide - chemistry | Rats | Blood Proteins - chemistry | Polysaccharides - pharmacology | Macrophages - enzymology | Particle Size | Macrophages - metabolism | Animals | Anti-Inflammatory Agents - chemistry | Silicon Dioxide - toxicity | Adsorption | Nanotubes, Carbon - chemistry | Cyclooxygenase 2 - metabolism | Lipopolysaccharides - pharmacology | Protein Binding | Macrophages - drug effects | Cell Proliferation - drug effects | Mice | Surface-Active Agents - chemistry | Nitric Oxide Synthase Type II - metabolism | Serum Albumin - metabolism | CARBON | BASIC BIOLOGICAL SCIENCES | SURFACTANTS | CATTLE | ALBUMINS | cyclooxygenase | TOXICITY | INDUCTION | LIPOPOLYSACCHARIDES | ADSORPTION | INCUBATION | PLASMA | carbon nanotubes | COATINGS | NANOTUBES | PLURONICS | SILICA | PROTEINS
Journal Article
Nano Letters, ISSN 1530-6984, 12/2011, Volume 11, Issue 12, pp. 5201 - 5207
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2016, Volume 65, Issue 1, pp. 207 - 217.e3
Objective Lipid mediators derived from omega-3 polyunsaturated fatty acids such as resolvin D1 (RvD1) accelerate the resolution of inflammation and have... 
Surgery | SURGERY | ACTIVATION | INTIMAL HYPERPLASIA | SMOOTH-MUSCLE MIGRATION | RESOLUTION | DISEASE | VASCULAR INFLAMMATION | ATHEROSCLEROSIS | PERIPHERAL VASCULAR DISEASE | PROLIFERATION | LIPID MEDIATORS | INSIGHTS | Muscle, Smooth, Vascular - metabolism | Hyperplasia | Myocytes, Smooth Muscle - pathology | Ki-67 Antigen - metabolism | Male | Aorta - metabolism | Angioplasty, Balloon - adverse effects | Drug Carriers | Neointima | Time Factors | Carotid Artery Diseases - pathology | Inflammation Mediators - metabolism | Drug Compounding | Myocytes, Smooth Muscle - drug effects | Carotid Artery Diseases - metabolism | Myocytes, Smooth Muscle - metabolism | Carotid Artery Diseases - drug therapy | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Poloxamer - chemistry | Cardiovascular Agents - administration & dosage | Carotid Artery Diseases - etiology | Cytoskeleton - pathology | Lactic Acid - chemistry | Docosahexaenoic Acids - chemistry | Aorta - drug effects | Cells, Cultured | Docosahexaenoic Acids - administration & dosage | Rats, Sprague-Dawley | Aorta - pathology | Cell Movement - drug effects | Muscle, Smooth, Vascular - pathology | Animals | Transcription Factor RelA - metabolism | Polyglycolic Acid - chemistry | Cytoskeleton - metabolism | Cell Proliferation - drug effects | Oxidative Stress - drug effects | Cytoskeleton - drug effects | Cardiovascular Agents - chemistry | Unsaturated fatty acids | Therapeutics | Homeopathy | Materia medica and therapeutics | Index Medicus
Journal Article
Scientific Reports, ISSN 2045-2322, 2015, Volume 5, Issue 1, pp. 8744 - 8744
Down syndrome (DS) patients with early-onset dementia share similar neurodegenerative features with Alzheimer's disease (AD). To recapitulate theADcell model,... 
TAU-PROTEIN | LOCALIZATION | DL-3-N-BUTYLPHTHALIDE | ANTIOXIDANT | MULTIDISCIPLINARY SCIENCES | AMYLOID PRECURSOR PROTEIN | MODEL | DEFICITS | IMPROVES COGNITIVE IMPAIRMENT | IPS CELLS | BETA | Angelica sinensis - chemistry | Embryonic Stem Cells - metabolism | Down Syndrome - metabolism | Humans | tau Proteins - metabolism | Alzheimer Disease - pathology | Time Factors | Amyloid beta-Peptides - metabolism | Phthalic Anhydrides - pharmacology | Cell Differentiation | Neurons - metabolism | Cell Culture Techniques | Phosphorylation - drug effects | Neurons - drug effects | tau Proteins - antagonists & inhibitors | Induced Pluripotent Stem Cells - metabolism | Poloxamer - chemistry | Down Syndrome - pathology | Peptide Fragments - metabolism | Induced Pluripotent Stem Cells - drug effects | Cells, Cultured | Neural Stem Cells - drug effects | Phthalic Anhydrides - chemistry | Cell Lineage | Microscopy, Confocal | Amyloid beta-Peptides - antagonists & inhibitors | Embryonic Stem Cells - drug effects | Models, Biological | Peptide Fragments - antagonists & inhibitors | Alzheimer Disease - metabolism | Neural Stem Cells - metabolism | Phosphorylation | Wnt protein | Mesenchyme | Toxicity | Forebrain | High-throughput screening | Drug screening | Drug development | Down's syndrome | Amniotic fluid | Dementia disorders | Amyloid | Alzheimer's disease | Age | Deposits | Neurodegenerative diseases | Neurons | Down syndrome | Neurofibrillary tangles | Prenatal diagnosis | Tau protein | Stem cells | Alzheimers disease | Pluripotency | Inhibitory postsynaptic potentials | Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 8, p. e72238
Purpose: Pluronic block copolymers are potent sensitizers of multidrug resistant cancers. SP1049C, a Pluronic-based micellar formulation of doxorubicin (Dox)... 
BREAST-CANCER CELLS | ALDEHYDE DEHYDROGENASE | PATHWAY | MULTIDISCIPLINARY SCIENCES | MDR | PLURONIC BLOCK-COPOLYMERS | ACUTE MYELOID-LEUKEMIA | IDENTIFICATION | EPIGENETIC CHANGES | TUMOR-INITIATING CELLS | CD133 | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Peptides - antagonists & inhibitors | Neoplastic Stem Cells - drug effects | Humans | Neoplasm Invasiveness - prevention & control | Gene Expression Regulation, Neoplastic | Glycoproteins - metabolism | Peptides - genetics | Wnt Proteins - metabolism | Antigens, CD - genetics | Antigens, CD - metabolism | Peptides - metabolism | Poloxamer - pharmacology | Wnt Proteins - genetics | ATP-Binding Cassette Transporters - genetics | Neoplastic Stem Cells - metabolism | Leukemia P388 - pathology | Doxorubicin - analogs & derivatives | ATP-Binding Cassette Transporters - metabolism | Neoplastic Stem Cells - pathology | Female | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Leukemia P388 - genetics | Wnt Signaling Pathway | Glycoproteins - genetics | Glycoproteins - antagonists & inhibitors | Poloxamer - analogs & derivatives | Leukemia P388 - metabolism | AC133 Antigen | beta Catenin - metabolism | Leukemia P388 - drug therapy | beta Catenin - genetics | Animals | beta Catenin - antagonists & inhibitors | Mice | Ascites | Wnt Proteins - antagonists & inhibitors | DNA Methylation - drug effects | Doxorubicin - pharmacology | ATP-Binding Cassette Transporters - antagonists & inhibitors | Drug Resistance, Neoplasm - drug effects | Medical research | Epigenetic inheritance | Anthracyclines | Drug resistance | Block copolymers | DNA | Stem cells | Mouse leukemia complex | Medicine, Experimental | Genetic aspects | Methylation | Esophageal cancer | Cancer | Adenocarcinoma | Wnt protein | Leukemia | Stem cell transplantation | Cytotoxicity | Activation | Metastasis | Cancer therapies | Doxorubicin | β-catenin | Signal transduction | Allografts | Safety engineering | Cell cycle | DNA methylation | Pharmaceutical sciences | Deoxyribonucleic acid--DNA | Aggressive behavior | Multidrug resistance | Breast cancer | Tumorigenicity | Gene expression | Esophagus | Signaling | Experimental design | Medical prognosis | Pharmacy | Epigenetics | Biomarkers | Nanotechnology | Tumors | Deoxyribonucleic acid
Journal Article